News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
471,974 Results
Type
Article (27634)
Company Profile (77)
Press Release (444258)
Multimedia
Podcasts (92)
Webinars (15)
Section
Business (115050)
Career Advice (793)
Deals (21347)
Drug Delivery (69)
Drug Development (76692)
Employer Resources (59)
FDA (12290)
Job Trends (9754)
News (224356)
Policy (20106)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (1)
Academia (1581)
Accelerated approval (52)
ADA (40)
Adcomms (39)
Allergies (177)
Alliances (33034)
ALS (214)
Alzheimer's disease (1737)
Antibody-drug conjugate (ADC) (474)
Approvals (12698)
Artificial intelligence (678)
ASCO (313)
Autoimmune disease (307)
Automation (53)
Bankruptcy (170)
Best Places to Work (8440)
BIOSECURE Act (14)
Biosimilars (141)
Biotechnology (58)
Bladder cancer (196)
Brain cancer (71)
Breast cancer (735)
Cancer (5699)
Cardiovascular disease (460)
Career advice (704)
Career pathing (22)
CAR-T (315)
CDC (32)
Celiac Disease (2)
Cell therapy (846)
Cervical cancer (50)
Clinical research (69758)
Collaboration (1808)
Commercialization (1)
Company closure (5)
Compensation (608)
Complete response letters (82)
COVID-19 (2280)
CRISPR (96)
C-suite (849)
Cystic fibrosis (121)
Data (7831)
Decentralized trials (3)
Denatured (27)
Depression (167)
Dermatology (80)
Diabetes (554)
Diagnostics (5023)
Digital health (59)
Diversity (14)
Diversity, equity & inclusion (25)
Drug discovery (277)
Drug pricing (87)
Drug shortages (9)
Duchenne muscular dystrophy (259)
Earnings (49533)
Editorial (48)
Employer branding (2)
Employer resources (59)
Events (72836)
Executive appointments (820)
FDA (15861)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (32)
Funding (1491)
Gene editing (211)
Generative AI (53)
Gene therapy (678)
GLP-1 (918)
Government (2724)
Grass and pollen (6)
Guidances (341)
Healthcare (12832)
Hematology (172)
HIV (75)
Huntington's disease (58)
IgA nephropathy (108)
Immunology and inflammation (272)
Immuno-oncology (99)
Indications (195)
Infectious disease (2581)
Inflammatory bowel disease (182)
Inflation Reduction Act (6)
Influenza (123)
Intellectual property (246)
Interviews (142)
IPO (10413)
IRA (23)
Job creations (1636)
Job search strategy (572)
JPM (39)
Kidney cancer (21)
Labor market (31)
Layoffs (382)
Leadership (23)
Legal (3831)
Liver cancer (88)
Longevity (24)
Lung cancer (774)
Lymphoma (436)
Machine learning (49)
Management (22)
Manufacturing (842)
Marketing (1)
MASH (212)
Medical affairs (1)
Medical device (10331)
Medtech (10472)
Mergers & acquisitions (12025)
Metabolic disorders (1430)
mRNA (171)
Multiple sclerosis (184)
NASH (20)
Neurodegenerative disease (421)
Neuropsychiatric disorders (110)
Neuroscience (3217)
Neurotech (1)
NextGen: Class of 2026 (4131)
Non-profit (2379)
Now hiring (25)
Obesity (635)
Opinion (225)
Ovarian cancer (225)
Pain (241)
Pancreatic cancer (331)
Parkinson's disease (367)
Partnered (25)
Patents (494)
Patient recruitment (744)
Peanut (61)
People (32945)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (21771)
Phase 2 (30952)
Phase 3 (23315)
Pipeline (8680)
Policy (185)
Postmarket research (2016)
Preclinical (6500)
Press Release (33)
Prostate cancer (310)
Psychedelics (62)
Radiopharmaceuticals (307)
Rare diseases (1016)
Real estate (2988)
Recruiting (19)
Regulatory (18520)
Reports (27)
Research institute (1752)
Resumes & cover letters (117)
Rett syndrome (42)
RNA editing (19)
RSV (74)
Schizophrenia (173)
Series A (252)
Series B (191)
Service/supplier (8)
Sickle cell disease (83)
Special edition (14)
Spinal muscular atrophy (157)
Sponsored (43)
Startups (2111)
State (1)
Stomach cancer (13)
Supply chain (92)
Tariffs (28)
The Weekly (65)
Vaccines (935)
Venture capital (75)
Weight loss (404)
Women's health (114)
Worklife (9)
Date
Today (94)
Last 7 days (349)
Last 30 days (2076)
Last 365 days (24974)
2026 (12647)
2025 (25239)
2024 (28244)
2023 (31442)
2022 (40213)
2021 (42400)
2020 (39362)
2019 (31582)
2018 (23580)
2017 (22756)
2016 (20505)
2015 (24013)
2014 (16990)
2013 (13472)
2012 (14207)
2011 (14491)
2010 (13236)
Location
Africa (452)
Alabama (82)
Alaska (5)
Arizona (193)
Arkansas (11)
Asia (28930)
Australia (5422)
California (10989)
Canada (2782)
China (1270)
Colorado (478)
Connecticut (490)
Delaware (375)
Europe (65635)
Florida (1692)
Georgia (402)
Hawaii (3)
Idaho (49)
Illinois (849)
India (69)
Indiana (562)
Iowa (19)
Japan (500)
Kansas (79)
Kentucky (45)
Louisiana (42)
Maine (42)
Maryland (1235)
Massachusetts (7880)
Michigan (291)
Minnesota (599)
Mississippi (6)
Missouri (136)
Montana (34)
Nebraska (19)
Nevada (116)
New Hampshire (77)
New Jersey (3048)
New Mexico (26)
New York (3034)
North Carolina (1415)
North Dakota (10)
Northern California (5560)
Ohio (375)
Oklahoma (16)
Oregon (34)
Pennsylvania (2229)
Puerto Rico (20)
Rhode Island (35)
South America (593)
South Carolina (77)
South Dakota (1)
Southern California (4407)
Tennessee (168)
Texas (1816)
United States (39245)
Utah (271)
Vermont (2)
Virginia (251)
Washington D.C. (56)
Washington State (894)
West Virginia (3)
Wisconsin (132)
Wyoming (2)
471,974 Results for "trial by fire solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Huntington’s disease
FDA Official Fires Back at UniQure, Doubles Down on Sham-Controlled Trial
UniQure does not have to drill placebo burr holes in the skulls of patients with Huntington’s disease, an unnamed FDA senior official said on Thursday. Instead, the company would anesthetize them and put “one to three nicks” in their scalp.
March 6, 2026
·
2 min read
·
Tristan Manalac
Policy
HHS debuts ‘unprecedented’ initiative to ‘restore American leadership’ in clinical trials
Among the health department’s efforts is an expedited investigational new drug pilot program that would leverage collaborations with U.S. research institutions to reduce early trial timelines by as much as 12 months.
June 22, 2026
·
3 min read
·
Heather McKenzie
Press Releases
Paradigm Health Implements New Clinical Trial Solution to Support Observational Study Presented at ASCO
June 1, 2026
·
5 min read
FDA
Makary, Prasad Under Fire as FDA Turmoil Reaches President Trump
Following the FDA’s refusal to review Moderna’s investigational mRNA flu vaccine last week, Commissioner Marty Makary faced questions from the U.S. president about the agency’s handling of vaccines. It’s a clear signal that the tension long brewing at the drug regulator has now gone all the way to the top.
February 20, 2026
·
7 min read
·
Heather McKenzie
Psychedelics
Despite FDA trial clearance, ibogaine metabolite won’t receive red carpet treatment
DemeRx is launching the first U.S. clinical trial of an ibogaine-derived drug candidate, marking a pivotal moment for a controversial psychedelic long sidelined by safety concerns.
June 15, 2026
·
10 min read
·
Gabrielle Masson
Business
Novo hit with cybersecurity breach, urges vigilance among trial participants
Novo Nordisk said that the information affected by the breach shouldn’t allow third parties to “identify participants in our clinical trials” despite “unauthorized access” to patients’ personal data.
June 12, 2026
·
2 min read
·
Tristan Manalac
Drug Development
Be Bio bins hemophilia B cell therapy trial—the biotech’s lead program
Be Biopharma’s terminated trial is the latest setback in the hemophilia space, where companies like Pfizer and BioMarin have opted to pull their respective products from the market after weak traction.
June 17, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Dr. Oladayo Oyelola Joins TrialAssure’s Advisory Board to Support Clinical Trial Transparency Strategy
Former Daiichi Sankyo transparency leader brings more than 30 years of experience across pharmaceutical research, clinical development, and global clinical trial disclosure
June 11, 2026
·
1 min read
Press Releases
ACHIEVE Trials Demonstrate Comparative Benefits of Novel, Small-Molecule Oral GLP-1 RA, Expanding Oral Treatment Options for Patient Population in Need of Alternative Solutions
June 9, 2026
·
9 min read
Press Releases
Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT)
May 5, 2026
·
5 min read
1 of 47,198
Next
